IRWD - Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IEX Last Trade
5.05
-0.060 -1.188%
Share volume: 1,325,722
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.11
-0.06
-1.17%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-16 | 2023-05-04 | 2023-08-09 | 2023-11-09 | 2024-02-16 | 2024-05-09 | |
| Total revenue | 97.231 M | 108.637 M | 107.199 M | 104.061 M | 107.382 M | 113.739 M | 117.553 M | 74.877 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 97.231 M | 108.637 M | 107.199 M | 104.061 M | 107.382 M | 113.739 M | 117.553 M | 74.877 M | |
| 11.73% | -1.32% | -2.93% | 3.19% | 5.92% | 3.35% | -36.30% | |||
| Operating expenses | 41.576 M | 40.164 M | 38.836 M | 43.964 M | 87.061 M | 69.031 M | 74.343 M | 63.420 M | |
| Selling general and admin | 30.124 M | 28.619 M | 28.390 M | 31.117 M | 52.484 M | 36.046 M | 38.667 M | 37.605 M | |
| Research and development | 11.452 M | 11.545 M | 10.446 M | 12.847 M | 34.577 M | 32.985 M | 35.676 M | 25.815 M | |
| Total expenses | 41.576 M | 40.164 M | 38.836 M | 43.964 M | 87.061 M | 69.031 M | 74.343 M | 63.420 M | |
| -3.40% | -3.31% | 13.20% | 98.03% | -20.71% | 7.70% | -14.69% | |||
| Operating income | 55.655 M | 68.473 M | 68.363 M | 60.097 M | 20.321 M | 44.708 M | 43.210 M | 11.457 M | |
| Ebit | 55.655 M | 68.473 M | 68.363 M | 60.097 M | 20.321 M | 44.708 M | 43.210 M | 11.457 M | |
| Pretax income | 53.785 M | 69.907 M | 72.265 M | 65.861 M | -1.076 B | 31.932 M | 30.360 M | 4.958 M | |
| 29.97% | 3.37% | -8.86% | -1,734.08% | -102.97% | -4.92% | -83.67% | |||
| Income tax | 16.705 M | 19.590 M | 23.398 M | 20.147 M | 13.256 M | 17.982 M | 32.105 M | 9.120 M | |
| Net income basic | 37.080 M | 50.317 M | 48.867 M | 45.714 M | -1.062 B | 15.321 M | -1.087 M | -4.162 M | |
| 35.70% | -2.88% | -6.45% | -2,423.55% | 101.44% | -107.09% | -282.89% | |||
| Net income | 37.080 M | 50.317 M | 48.867 M | 45.714 M | -1.062 B | 15.321 M | -1.087 M | -4.162 M | |
| 35.70% | -2.88% | -6.45% | -2,423.55% | 101.44% | -107.09% | -282.89% |